Economic Evaluation of Strategies for Restarting Anticoagulation Therapy After a First Event of Unprovoked Venous Thromboembolism

Journal of Thrombosis and Haemostasis - United Kingdom
doi 10.1111/jth.13739
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulation Therapy

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2015English

Long-Term Risk of Venous Thrombosis After Stopping Anticoagulants for a First Unprovoked Event: A Multi-National Cohort

Thrombosis Research
Hematology
2016English

Validation of a Prognostic Score for Hidden Cancer in Unprovoked Venous Thromboembolism

PLoS ONE
Multidisciplinary
2018English

Protocol for a Systematic Review of Prognostic Models for the Recurrence of Venous Thromboembolism (VTE) Following Treatment for a First Unprovoked VTE

Systematic Reviews
Medicine
2013English

A Risk Score for Prediction of Recurrence in Patients With Unprovoked Venous Thromboembolism (DAMOVES)

European Journal of Internal Medicine
Internal Medicine
2016English

Utility of Plasma D-Dimer in Decision to Continue Anticoagulation Therapy Following Idiopathic Venous Thromboembolism

Kansas Journal of Medicine
2015English

Real World Experience at a Single Centre Using Low Dose Direct Oral Anticoagulants After Unprovoked Venous Thromboembolism

British Journal of Haematology
Hematology
2019English

Anticoagulation for the Initial Treatment of Venous Thromboembolism in Patients With Cancer

Cochrane Database of Systematic Reviews
2014English

Anticoagulation Treatment Using NOAC in Patients With Venous Thromboembolism

International Journal of Arrhythmia
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy